GlobalData provides unique and market-leading data and insights into the ophthalmology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Glaucoma: Epidemiology Forecast to 2030

  • $3,995
  • December 2021
Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes...

Glaucoma – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Glaucoma - Global Clinical Trials Review, H2, 2021" provides an overview of Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical...

Macular Edema – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Macular Edema - Global Clinical Trials Review, H2, 2021" provides an overview of Macular Edema Clinical trials scenario. This report provides top line data relating to...

Wet (Neovascular / Exudative) Macular Degeneration – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, H2, 2021" provides an overview of Wet (Neovascular / Exudative) Macular Degeneration Clinical trials scenario....

Central Retinal Vein Occlusion – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Central Retinal Vein Occlusion - Global Clinical Trials Review, H2, 2021" provides an overview of Central Retinal Vein Occlusion Clinical trials scenario. This report provides top...

Retinitis Pigmentosa (Retinitis) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Retinitis Pigmentosa (Retinitis) - Global Clinical Trials Review, H2, 2021" provides an overview of Retinitis Pigmentosa (Retinitis) Clinical trials scenario. This report provides top line data...

Graves’ Ophthalmopathy – Global Clinical Trials Review, H2, 2021

  • $2,500
  • July 2021
GlobalData's clinical trial report, “Graves' Ophthalmopathy - Global Clinical Trials Review, H2, 2021" provides an overview of Graves' Ophthalmopathy Clinical trials scenario. This report provides top line data relating to...

Keratoconjunctivitis Sicca (Dry Eye) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • July 2021
GlobalData's clinical trial report, “Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, H2, 2021" provides an overview of Keratoconjunctivitis Sicca (Dry Eye) Clinical trials scenario. This report provides top...

Glaucoma – Global Clinical Trials Review, H1, 2021

  • $2,500
  • June 2021
GlobalData's clinical trial report, “Glaucoma - Global Clinical Trials Review, H1, 2021" provides an overview of Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical...

Uveitis – Epidemiology Forecast to 2029

  • $3,995
  • June 2021
Uveitis is a condition characterized by the inflammation of the uveal tract (iris, ciliary body, and choroid), but can also cause the inflammation of nearby tissues, such as the retina,...